An outpouring of recent research has shown the outcome benefits of early revascularization and complete revascularization over alternatives in certain cases.
A single-center analysis ahead of full ISCHEMIA trial results challenges mixed data and suggests better survival rates for early revascularization when compared to medical therapy in patients with stable CAD and myocardial ischemia.
And while the risk of PCI in non-culprit lesions was previously unclear, new results from the COMPLETE trial suggests complete revascularization is superior to culprit-only PCI.
|
